MAPK3 and colonic neoplasm: Thus, we propose that NaV1.5 VGSC activity confers an oncogenic advantage to colon cancer cells by stimulating PKA/Rap1B/MEK/ERK1/2 to transcriptionally up-regulate genes required for invasion.